Free Trial

HLS Therapeutics (HLS) Competitors

HLS Therapeutics logo
C$5.40 +0.04 (+0.75%)
As of 03:59 PM Eastern

HLS vs. ACB, WEED, CPH, FIRE, OGI, EPI, ICC, RIV, LEAF, and CRDL

Should you be buying HLS Therapeutics stock or one of its competitors? The main competitors of HLS Therapeutics include Aurora Cannabis (ACB), Canopy Growth (WEED), Cipher Pharmaceuticals (CPH), Supreme Cannabis (FIRE), Organigram (OGI), ESSA Pharma (EPI), ICC Labs (ICC), RIV Capital (RIV), Leaf Mobile (LEAF), and Cardiol Therapeutics (CRDL). These companies are all part of the "drug manufacturers - specialty & generic" industry.

HLS Therapeutics vs. Its Competitors

Aurora Cannabis (TSE:ACB) and HLS Therapeutics (TSE:HLS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

In the previous week, Aurora Cannabis had 1 more articles in the media than HLS Therapeutics. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for HLS Therapeutics. HLS Therapeutics' average media sentiment score of 1.36 beat Aurora Cannabis' score of 0.00 indicating that HLS Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Aurora Cannabis Neutral
HLS Therapeutics Positive

Aurora Cannabis has a net margin of -22.55% compared to HLS Therapeutics' net margin of -38.70%. Aurora Cannabis' return on equity of -8.36% beat HLS Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-22.55% -8.36% -1.87%
HLS Therapeutics -38.70%-25.27%-2.89%

Aurora Cannabis presently has a consensus target price of C$8.75, indicating a potential upside of 22.72%. HLS Therapeutics has a consensus target price of C$5.00, indicating a potential downside of 7.41%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, analysts clearly believe Aurora Cannabis is more favorable than HLS Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00
HLS Therapeutics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

4.3% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 0.4% of HLS Therapeutics shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HLS Therapeutics has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than HLS Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$357.88M1.12-C$44.16M-C$0.33-21.61
HLS TherapeuticsC$56.42M3.00-C$15.53M-C$0.48-11.25

Aurora Cannabis has a beta of 0.949503, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, HLS Therapeutics has a beta of 0.676933, indicating that its stock price is 32% less volatile than the S&P 500.

Summary

Aurora Cannabis beats HLS Therapeutics on 11 of the 16 factors compared between the two stocks.

Get HLS Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLS vs. The Competition

MetricHLS TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$169.53MC$1.69BC$5.75BC$9.27B
Dividend Yield4.30%2.93%6.66%6.53%
P/E Ratio-11.25108.0662.2624.74
Price / Sales3.001,299.58537.349.21
Price / Cash15.2210.3725.7083.29
Price / Book2.1511.4111.195.32
Net Income-C$15.53MC$20.70BC$3.28BC$301.20M
7 Day Performance3.45%0.98%0.15%4.04%
1 Month Performance8.00%4.80%8.34%10.62%
1 Year Performance62.65%3.52%54.21%34.81%

HLS Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLS
HLS Therapeutics
0.5927 of 5 stars
C$5.40
+0.7%
C$5.00
-7.4%
+61.4%C$169.53MC$56.42M-11.2591Positive News
ACB
Aurora Cannabis
0.1578 of 5 stars
C$6.58
flat
C$8.75
+33.0%
-9.4%C$359.98MC$195.83M-8.131,073Gap Down
WEED
Canopy Growth
0.3546 of 5 stars
C$1.68
-2.9%
C$1.55
-7.7%
-65.0%C$270.26MC$519.68M-0.252,700Positive News
Gap Down
CPH
Cipher Pharmaceuticals
0.3254 of 5 stars
C$14.61
+2.5%
C$14.75
+1.0%
-16.1%C$262.30MC$19.03M16.135
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
OGI
Organigram
2.9734 of 5 stars
C$2.07
-1.0%
C$3.33
+60.6%
-4.8%C$255.73MC$180.58M-4.38987Gap Down
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up
RIV
RIV Capital
N/AN/AN/AN/AC$213.65MC$11.33M-1.6312
LEAF
Leaf Mobile
N/AN/AN/AN/AC$198.42MC$83.74M58.86150Positive News
CRDL
Cardiol Therapeutics
N/AC$1.60
+1.9%
N/A-42.9%C$132.77MN/A-3.1420

Related Companies and Tools


This page (TSE:HLS) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners